SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-012198
Filing Date
2019-02-21
Accepted
2019-02-21 17:42:06
Documents
2
Period of Report
2019-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3026
2 POA DOCUMENT poa.txt EX-24.3_835190 3048
  Complete submission text file 0001209191-19-012198.txt   7473
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRINCIPIA BIOPHARMA INC. 220 E. GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Thomas Dolca (Reporting) CIK: 0001768239 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38653 | Film No.: 19623121